{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:10Z","timestamp":1793642350979,"version":"4.5.1"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,12,12]]},"abstract":"<jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagonists (VKAs) with continuous-flow LVADs without conclusive evidence of efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine whether excluding aspirin as part of the antithrombotic regimen with a fully magnetically levitated LVAD is safe and decreases bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN, SETTING, and PARTICIPANTS<\/jats:title>\n                    <jats:p>This international, randomized, double-blind, placebo-controlled study of aspirin (100 mg\/d) vs placebo with VKA therapy in patients with advanced heart failure with an LVAD was conducted across 51 centers with expertise in treating patients with advanced heart failure across 9 countries. The randomized population included 628 patients with advanced heart failure implanted with a fully magnetically levitated LVAD (314 in the placebo group and 314 in the aspirin group), of whom 296 patients in the placebo group and 293 in the aspirin group were in the primary analysis population, which informed the primary end point analysis. The study enrolled patients from July 2020 to September 2022; median follow-up was 14 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Patients were randomized in a 1:1 ratio to receive aspirin (100 mg\/d) or placebo in addition to an antithrombotic regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOMES AND MEASURES<\/jats:title>\n                    <jats:p>The composite primary end point, assessed for noninferiority (\u221210% margin) of placebo, was survival free of a major nonsurgical (&amp;amp;gt;14 days after implant) hemocompatibility-related adverse events (including stroke, pump thrombosis, major bleeding, or arterial peripheral thromboembolism) at 12 months. The principal secondary end point was nonsurgical bleeding events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of the 589 analyzed patients, 77% were men; one-third were Black and 61% were White. More patients were alive and free of hemocompatibility events at 12 months in the placebo group (74%) vs those taking aspirin (68%). Noninferiority of placebo was demonstrated (absolute between-group difference, 6.0% improvement in event-free survival with placebo [lower 1-sided 97.5% CI, \u22121.6%];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Aspirin avoidance was associated with reduced nonsurgical bleeding events (relative risk, 0.66 [95% confidence limit, 0.51-0.85];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002) with no increase in stroke or other thromboembolic events, a finding consistent among diverse subgroups of patient characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS AND RELEVANCE<\/jats:title>\n                    <jats:p>In patients with advanced heart failure treated with a fully magnetically levitated LVAD, avoidance of aspirin as part of an antithrombotic regimen, which includes VKA, is not inferior to a regimen containing aspirin, does not increase thromboembolism risk, and is associated with a reduction in bleeding events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04069156\">NCT04069156<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.23204","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T14:30:38Z","timestamp":1699713038000},"page":"2171","source":"Crossref","is-referenced-by-count":189,"title":["Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure"],"prefix":"10.1001","volume":"330","author":[{"given":"Mandeep R.","family":"Mehra","sequence":"first","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Netuka","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Medicine, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Katz","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis D.","family":"Pagani","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich P.","family":"Jorde","sequence":"additional","affiliation":[{"name":"Montefiore Einstein Center for Heart and Vascular Care, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ivak","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Experimental Medicine, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cowger","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ransom","sequence":"additional","affiliation":[{"name":"Baptist Health Medical Center, Little Rock, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bansal","sequence":"additional","affiliation":[{"name":"Ochsner Medical Center, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirnela","family":"Byku","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Bitar","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Hall","sequence":"additional","affiliation":[{"name":"Baylor University Hospital, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zimpfer","sequence":"additional","affiliation":[{"name":"Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Vega","sequence":"additional","affiliation":[{"name":"Emory University Hospital, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manreet K.","family":"Kanwar","sequence":"additional","affiliation":[{"name":"Allegheny Health Network, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Saeed","sequence":"additional","affiliation":[{"name":"Montefiore Einstein Center for Heart and Vascular Care, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Montefiore Einstein Center for Heart and Vascular Care, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cogswell","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical Center Fairview Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farooq H.","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Medstar Washington Hospital Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Danter","sequence":"additional","affiliation":[{"name":"Kansas University Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Pya","sequence":"additional","affiliation":[{"name":"National Research Center for Cardiac Surgery, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Phancao","sequence":"additional","affiliation":[{"name":"Miami Transplant Institute\u2014Jackson Memorial, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Henderson","sequence":"additional","affiliation":[{"name":"Abbott, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Crandall","sequence":"additional","affiliation":[{"name":"Abbott, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Sundareswaran","sequence":"additional","affiliation":[{"name":"Abbott, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Soltesz","sequence":"additional","affiliation":[{"name":"The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry D.","family":"Estep","sequence":"additional","affiliation":[{"name":"The Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ARIES-HM3 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Silvestry","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antone","family":"Tatooles","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Siulemanjee","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Sheridan","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Gulati","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Chung","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Delmas","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Milano","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dos Santos","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Atluri","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Horstmanshof","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Alessandro","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Nathan","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Eckman","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anelechi","family":"Anyanwu","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mara","family":"Scandroglio","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ortalda","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Molina","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Abraham","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sern","family":"Lim","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Adamson","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Ravichandran","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hayward","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hiesinger","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Entwistle","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Conway","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Adler","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grinstein","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brieke","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Keebler","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Alexis","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Gosev","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Selzman","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Kaye","sequence":"additional","affiliation":[{"name":"for the ARIES-HM3 Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8 pt 1","key":"joi230137r1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jchf.2023.05.013","article-title":"Life-prolonging benefits of LVAD therapy in advanced heart failure: a clinician\u2019s action and communication aid.","volume":"11","author":"Mehra","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"12","key":"joi230137r2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial.","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"issue":"21","key":"joi230137r3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure.","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"joi230137r4","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/ehf2.v10.4","article-title":"Gastrointestinal bleeding on continuous-flow left ventricular assist device therapy.","volume":"10","author":"Hammer","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"7","key":"joi230137r5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jchf.2022.03.007","article-title":"Hospitalization patterns and impact of a magnetically-levitated left ventricular assist device in the MOMENTUM 3 trial.","volume":"10","author":"Vidula","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"8","key":"joi230137r6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.healun.2019.05.006","article-title":"Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: a prospective multicenter clinical trial.","volume":"38","author":"Bansal","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"joi230137r7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.healun.2017.05.008","article-title":"Bleeding and thrombosis associated with ventricular assist device therapy.","volume":"36","author":"Shah","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"joi230137r8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/aor.v47.1","article-title":"Gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices: a comprehensive review.","volume":"47","author":"Del Rio-Pertuz","year":"2023","journal-title":"Artif Organs"},{"issue":"4","key":"joi230137r9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ejhf.2018.20.issue-4","article-title":"Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device.","volume":"20","author":"Consolo","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"joi230137r10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.healun.2013.04.004","article-title":"HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial.","volume":"32","author":"Slaughter","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"joi230137r11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.healun.2013.12.001","article-title":"An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.","volume":"33","author":"Najjar","year":"2014","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"joi230137r12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.healun.2020.03.001","article-title":"Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 study.","volume":"39","author":"Saeed","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"joi230137r13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ejhf.2019.21.issue-6","article-title":"Do we need aspirin in HeartMate 3 patients?","volume":"21","author":"Consolo","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"joi230137r14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.healun.2020.06.012","article-title":"Two-year outcome of warfarin monotherapy in HeartMate 3 left ventricular assist device: a single-center experience.","volume":"39","author":"Lim","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"joi230137r15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/ejhf.v23.7","article-title":"Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"joi230137r16","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.118.035722","article-title":"Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study.","volume":"138","author":"Mehra","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"joi230137r17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.hlc.2009.11.002","article-title":"Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease.","volume":"19","author":"Kidson-Gerber","year":"2010","journal-title":"Heart Lung Circ"},{"issue":"3","key":"joi230137r18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/B:THRO.0000011377.78585.63","article-title":"Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.","volume":"15","author":"Schmitt","year":"2003","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"joi230137r19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.healun.2019.02.009","article-title":"Prothrombotic activity of cytokine-activated endothelial cells and shear-activated platelets in the setting of ventricular assist device support.","volume":"38","author":"Apostoli","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"joi230137r20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease.","volume":"16","author":"Patrono","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"joi230137r21","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans.","volume":"183","author":"Morris","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"joi230137r22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","article-title":"Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) randomized clinical trial.","volume":"5","author":"Goldstein","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"10","key":"joi230137r23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008360","article-title":"Impact of race on clinical outcomes after implantation with a fully magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 trial.","volume":"14","author":"Sheikh","year":"2021","journal-title":"Circ Heart Fail"},{"key":"joi230137r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.08.020","article-title":"Clinical outcomes with a fully magnetically levitated left ventricular assist device among women and men.","author":"Ramu","year":"2023","journal-title":"J Am Coll Cardiol HF"},{"issue":"9","key":"joi230137r25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.healun.2020.05.001","article-title":"Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: an IMACS analysis.","volume":"39","author":"Mirza","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"joi230137r26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/ejhf.v24.7","article-title":"Global challenges in left ventricular assist device therapy: a tale across two continents.","volume":"24","author":"Nayak","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2811936\/jama_mehra_2023_oi_230137_1701364733.7741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T11:29:01Z","timestamp":1702380541000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2811936"}},"subtitle":["The ARIES-HM3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":26,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,12,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.23204","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,12]]}}}